© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | HERED OVA CA RLTD DO PNL 17 | Medium Descr | HERED OVA CA RLTD DO TRGT MRNA SEQ ALYS 17 GENE | Long Descr | Hereditary ovarian cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), targeted mRNA sequence analysis panel (17 genes) (List separately in addition to code for primary procedure) | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
This is an add-on code that must be used in conjunction with one of these primary codes.
| 0103U | Female Edit APC A Hereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (24 genes [sequencing and deletion/duplication], EPCAM [deletion/duplication only]) | 81162 | Adult 15-124 Resequenced Code MPFS Status: Statutory exclusion (from MPFS, may be paid under other methodologies) APC A BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements) | 81432 | Changed Code for 2025 MPFS Status: Statutory exclusion (from MPFS, may be paid under other methodologies) APC A Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer, hereditary pancreatic cancer, hereditary prostate cancer), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2020-01-01 | Added | First appearance in code book. |
| 2019-10-01 | Added | Code Added |
Get instant expert-level medical coding assistance.